PMDA drug package insert
オキサリプラチン点滴静注液50mg/10mL「ホスピーラ」
PMDA Prescription drug · ファイザー株式会社 · package insert Aug 18, 2025
Key facts
| Brand names | オキサリプラチン点滴静注液50mg/10mL「ホスピーラ」, オキサリプラチン点滴静注液100mg/20mL「ホスピーラ」, オキサリプラチン点滴静注液200mg/40mL「ホスピーラ」 |
|---|---|
| Nonproprietary names | オキサリプラチン |
| Companies | 製造販売元（輸入元）／ファイザー株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291410A1061, 4291410A2068, 4291410A3153 |
| Approval numbers | 22600AMX00954, 22600AMX00955, 22700AMX00764 |
| Package insert edition | 第2版 |
| Package insert date | Aug 18, 2025 |
| PMDA document key | 672212_4291410A1061_3 |
| PMDA company code | 672212 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: